P38 MAP Kinase links CAR activation and inactivation in the nucleus via phosphorylation at threonine 38

N/ACitations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Nuclear receptor constitutive androstane receptor (CAR, NR1I3), which regulates hepatic drug and energy metabolisms as well as cell growth and death, is sequestered in the cytoplasm as its inactive form phosphorylated at threonine 38. CAR activators elicit dephosphorylation, and nonphosphorylated CAR translocates into the nucleus to activate its target genes. CAR was previously found to require p38 mitogen-Activated protein kinase (MAPK) to transactivate the cytochrome P450 2B (CYP2B) genes. Herewe have demonstrated that p38 MAPK forms a complex with CAR, enables it to bind to the response sequence, phenobarbital-responsive enhancer module (PBREM), within the CYP2B promoter, and thus recruits RNA polymerase II to activate transcription. Subsequently, p38 MAPK elicited rephosphorylation of threonine 38 to inactivate CAR and exclude it from the nucleus. Thus, nuclear p38MAPK exerted dual regulation by sequentially activating and inactivating CAR-mediated transcription through phosphorylation of threonine 38.

Cite

CITATION STYLE

APA

Hori, T., Moore, R., & Negishi, M. (2016). P38 MAP Kinase links CAR activation and inactivation in the nucleus via phosphorylation at threonine 38. Drug Metabolism and Disposition, 44(6), 871–876. https://doi.org/10.1124/dmd.116.070235

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free